1. Ilozumba, Mmadili N, Yao, Song, Llanos, Adana A M, Ambrosone, Christine B, Cheng, Ting-Yuan David. 2022. mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients. In Discover oncology, 13, 34. doi:10.1007/s12672-022-00497-y. https://pubmed.ncbi.nlm.nih.gov/35608730/
2. Ma, Qiang, Yang, Yipin, Chen, Shuwen, Gong, Peng, Hao, Jiqing. 2024. Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines. In Molecular biology reports, 51, 229. doi:10.1007/s11033-023-09134-5. https://pubmed.ncbi.nlm.nih.gov/38281249/
3. Slattery, Martha L, Lundgreen, Abbie, Herrick, Jennifer S, Wolff, Roger K. 2010. Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer. In Mutation research, 706, 13-20. doi:10.1016/j.mrfmmm.2010.10.005. https://pubmed.ncbi.nlm.nih.gov/21035469/
4. Li, Rong, Pu, Xia, Chang, Joe Y, Han, Baohui, Wu, Xifeng. 2016. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer. In PloS one, 11, e0150467. doi:10.1371/journal.pone.0150467. https://pubmed.ncbi.nlm.nih.gov/26991123/
5. Sun, Zhifu, Wang, Liang, Eckloff, Bruce W, You, Ming, Yang, Ping. 2014. Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers. In BMC medical genomics, 7, 32. doi:10.1186/1755-8794-7-32. https://pubmed.ncbi.nlm.nih.gov/24894543/
6. Hao, Xiaoyan, Du, Yufeng, Qian, Li, Li, Dan, Liu, Xuejun. 2017. Upregulation of long noncoding RNA AP003419.16 predicts high risk of aging‑associated idiopathic pulmonary fibrosis. In Molecular medicine reports, 16, 8085-8091. doi:10.3892/mmr.2017.7607. https://pubmed.ncbi.nlm.nih.gov/28944926/
智鼠故事 
